Amphastar Pharmaceuticals
AMPH
#4974
Rank
โ‚น116.38 B
Marketcap
โ‚น2,442
Share price
1.36%
Change (1 day)
-34.10%
Change (1 year)

Revenue for Amphastar Pharmaceuticals (AMPH)

Revenue in 2024 (TTM): โ‚น61.54 Billion

According to Amphastar Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น63.19 Billion. an increase over the revenue in the year 2023 that were of โ‚น53.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amphastar Pharmaceuticals from 2013 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น62.79 B17.05%
2023 โ‚น53.64 B29.92%
2022 โ‚น41.29 B26.72%
2021 โ‚น32.58 B27.35%
2020 โ‚น25.58 B11.3%
2019 โ‚น22.98 B11.57%
2018 โ‚น20.60 B34.35%
2017 โ‚น15.33 B-11.56%
2016 โ‚น17.33 B3.74%
2015 โ‚น16.71 B25.31%
2014 โ‚น13.33 B-6%
2013 โ‚น14.18 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น2.71 B-95.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.32 B-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.86 B-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.97 B-98.46%๐Ÿ‡บ๐Ÿ‡ธ USA